Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Auvinen M.I.,,Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma,2002,Journal of Clinical Oncology,99,10.1200/JCO.2002.09.011,Finland,Article,Helsinki,0,Journal,2-s2.0-0036644913
Spechler S.,,Barrett's esophagus,2002,New England Journal of Medicine,516,10.1056/NEJMcp012118,United States;United States,Review,Dallas;Dallas,0,Journal,2-s2.0-0037075991
Jankowski J.,,Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west [2],2002,Gastroenterology,126,10.1053/gast.2002.31599,United Kingdom,Article,Birmingham,0,Journal,2-s2.0-0036163770
Souza R.,,Review article: A conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus,2001,Alimentary Pharmacology and Therapeutics,50,10.1046/j.1365-2036.2001.01046.x,United States,Review,Dallas,0,Journal,2-s2.0-0034923764
Shureiqi I.,,Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression,2001,Cancer Research,82,,United States,Article,Houston,0,Journal,2-s2.0-0035874883
Wijnhoven B.,,Molecular biology of Barrett's adenocarcinoma,2001,Annals of Surgery,93,10.1097/00000658-200103000-00005,Netherlands,Review,Rotterdam,0,Journal,2-s2.0-0035116072
Kawakami K.,,Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma,2000,Journal of the National Cancer Institute,315,10.1093/jnci/92.22.1805,United States,Article,Los Angeles,1,Journal,2-s2.0-0034669126
Couvelard A.,,Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression,2000,Journal of Pathology,91,10.1002/1096-9896(2000)9999:9999<::AID-PATH709>3.0.CO;2-F,France,Article,Clichy,0,Journal,2-s2.0-0033835475
Eads C.,,Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma,2000,Cancer Research,318,,United States,Article,Los Angeles,0,Journal,2-s2.0-0034665332
Reid B.,,Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets,2000,American Journal of Gastroenterology,570,10.1016/S0002-9270(00)00988-6,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0033915683
Hanahan D.,,The hallmarks of cancer,2000,Cell,19621,10.1016/S0092-8674(00)81683-9,United States,Review,San Francisco,1,Journal,2-s2.0-0034614637
Younes M.,,Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus,2000,Human Pathology,33,10.1053/hp.2000.6715,United States;United States;United States,Article,Houston;Houston;Houston,0,Journal,2-s2.0-0034075810
Lord R.V.N.,,"Telomerase Reverse Transcriptase Expression is Increased Early in the Barrett's Metaplasia, Dysplasia, Adenocarcinoma Sequence",2000,Journal of Gastrointestinal Surgery,222,10.1016/S1091-255X(00)80049-9,,Article,,0,Journal,2-s2.0-0034146097
Christofori G.,,The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene,1999,Trends in Biochemical Sciences,614,10.1016/S0968-0004(98)01343-7,Austria,Review,Vienna,0,Journal,2-s2.0-0033079605
Giaccia A.,,The complexity of p53 modulation: Emerging patterns from divergent signals,1998,Genes and Development,1128,10.1101/gad.12.19.2973,United States,Review,Palo Alto,1,Journal,2-s2.0-0032192140
Morales C.,,In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma,1998,Cancer,105,10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M,United States,Article,Dallas,1,Journal,2-s2.0-0031865011
Wilson K.,,Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas,1998,Cancer Research,543,,United States;United States,Article,Baltimore;Baltimore,0,Journal,2-s2.0-0032528178
Hetts S.,,To Die or not to die: An overview of apoptosis and its role in disease,1998,Journal of the American Medical Association,453,10.1001/jama.279.4.300,United States,Review,Boston,0,Journal,2-s2.0-0032573853
Achen M.,,Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4),1998,Proceedings of the National Academy of Sciences of the United States of America,962,10.1073/pnas.95.2.548,Australia,Article,Melbourne,1,Journal,2-s2.0-0031905861
Klump B.,,Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus,1998,Gastroenterology,162,10.1016/S0016-5085(98)70016-2,Germany,Article,Tubingen,0,Journal,2-s2.0-0031762798
Bailey T.,,Altered cadherin and catenin complexes in the Barrett's esophagus- dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation,1998,American Journal of Pathology,191,,United Kingdom,Article,Cranfield,0,Journal,2-s2.0-0031984835
Shay J.,,A survey of telomerase activity in human cancer,1997,European Journal of Cancer Part A,2225,10.1016/S0959-8049(97)00062-2,United States,Article,Dallas,0,Journal,2-s2.0-0031010342
Tsujii M.,,Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2,1995,Cell,2080,10.1016/0092-8674(95)90127-2,United States,Article,,1,Journal,2-s2.0-0028803728
Swami S.,,"E‚ÄêCadherin Expression in Gastroesophageal Reflux Disease, Barrett's Esophagus, and Esophageal Adenocarcinoma: An Immunohistochemical and Immunoblot Study",1995,The American Journal of Gastroenterology,57,10.1111/j.1572-0241.1995.tb08076.x,United States;United States,Article,Palo Alto;Palo Alto,0,Journal,2-s2.0-0028984169
Brito M.J.,,Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables,1995,International Journal of Cancer,66,10.1002/ijc.2910600103,United Kingdom,Article,London,0,Journal,2-s2.0-0028966393
Hamelin R.,,TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus,1994,Gastroenterology,159,10.1016/0016-5085(94)90225-9,France,Article,Paris,0,Journal,2-s2.0-0028027356
Suda T.,,"Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family",1993,Cell,2371,10.1016/0092-8674(93)90326-L,Japan,Article,Suita,0,Journal,2-s2.0-0027145632
Jankowski J.,,Increased Expression of Epidermal Growth Factor Receptors in Barrett's Esophagus Associated with Alkaline Reflux: A Putative Model for Carcinogenesis,1993,The American Journal of Gastroenterology,45,10.1111/j.1572-0241.1993.tb07555.x,United Kingdom;United Kingdom,Article,London;Dundee,0,Journal,2-s2.0-0027405012
Younes M.,,"p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: A follow-up study",1993,Gastroenterology,181,10.1016/0016-5085(93)91058-P,United States;United States,Article,Houston;Houston,0,Journal,2-s2.0-0027330839
